Global
Contact Us
DKSH Healthcare’s culture is grounded in a strong sense of purpose, patient centricity, and belonging. Our shared purpose empowers us to deliver better healthcare for our partners, our patients, and our people, supporting better outcomes for the people we serve.
Asia’s healthcare landscape is undergoing a profound shift, driven by rising demand, regulatory complexity, and accelerating innovation. As healthcare companies look to capture growth opportunities across the region, the question is no longer whether to expand into Asia, but how to do so efficiently and sustainably. Increasingly, Hong Kong is emerging as a strategic gateway for companies seeking to navigate this complexity and scale across multiple markets. As a super connector, it enables companies to bridge global strategies with local execution, while providing a coordination point for international healthcare players to align regional strategies and adapt to individual markets.
The partnership between DKSH and Kyowa Kirin is built on strong engagement and consistent communication. Over time, it has become a high-impact partnership with broad regional coverage, driving strong sales performance, and sustaining momentum through strong team alignment.
X-linked hypophosphatemia, or XLH, is a rare genetic bone disorder that can affect children’s development when not detected early. Limited awareness, high screening costs, and uneven access to specialist care often delay diagnosis.
In today’s competitive healthcare landscape, sustainable growth requires strong execution on the ground, deep local insights, and a partner who can navigate complexity with consistency. This story highlights how the right foundations and shared commitment enable brands to scale confidently and achieve long-term success in the market.
Cervical cancer remains one of the most significant health challenges for women, ranking as the second most common cancer among women in Thailand. Human Papillomavirus (HPV) is the leading cause and often shows no symptoms, so many never realize they have been infected. While most cervical lesions regress naturally, 10 to 15 percent of infections can persist and, in some cases, progress to cervical cancer.
From Compliance to Competitive Edge: Redefining Sustainability in Healthcare Logistics In healthcare, the equation is even more critical. Logistics is not simply about efficiency: it is about safeguarding patient access to life-saving medicines, vaccines, and medical technologies. The challenge today is clear: how do we deliver reliability, resilience, and responsibility at the same time? At DKSH, sustainability is embedded into our corporate strategy, governance framework, and operational execution. It is not a side initiative. It is a strategic enabler.
Despite having a strong immuno-oncology portfolio, Bristol Myers Squibb (BMS) was looking for ways to fully leverage the rapid expansion of the cancer treatment market in Malaysia. To unlock this potential, BMS partnered with DKSH to provide market expertise and uncover opportunities for sustainable double-digit growth.
Although rare by definition, the collective impact of rare diseases is anything but insignificant. In the Asia Pacific (APAC) region, home to over half of the world’s population, more than 258 million people are estimated to be living with a rare disease. This staggering figure becomes even more pronounced on a global scale. Yet treatment options remain scarce, creating a pressing issue of healthcare equity. Addressing this challenge requires deeper understanding and urgent action.
On December 3, the world recognizes the International Day of Persons with Disabilities, this year under the United Nations theme, “Fostering disability-inclusive societies for advancing social progress.”
In an era where digital transformation is reshaping industries, healthcare stands at a crossroad. As patient needs become more complex and healthcare professionals (HCPs) demand timelier, personalized, data-driven interactions, traditional engagement models are falling short. While more than 80% of pharma executives report satisfaction with their current engagement strategies, only about 35% of HCPs feel their needs are being effectively met. Bridging this gap requires more than incremental change; it calls for a bold reimagining of healthcare operations powered by artificial intelligence (AI).
Healthcare logistics is no longer a tertiary subject. As the prevalence of infectious and non-communicable diseases rises alongside supply chain disruptions due to regional conflicts, ensuring unhindered access to medicines remains an urgent priority. However, balancing demand and supply is a significant challenge because of the complexities of distribution networks. One case in point is the extremely high demand for glucagon-like peptide-1 receptor agonists (GLP-1 agonists), which are groundbreaking for managing diabetes and aiding in weight loss. This trend is reflected in the market size, valued at USD 46.70 billion in 2024 and projected to reach USD 322.85 billion by 2034.
November 14 marks World Diabetes Day, an annual reminder of the growing global challenge posed by diabetes, one of the fastest-rising chronic conditions worldwide. According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20 – 79 years are currently living with diabetes, and this number is expected to exceed 640 million by 2030.
Every October, breast cancer awareness is symbolized by pink ribbons, fundraising events, and heightened public attention. Yet behind these symbols lies a far more complex reality: for millions of women across Asia and beyond, breast cancer is not simply a matter of awareness, but a daily struggle due to multiple factors such as late diagnosis, prohibitive treatment costs, and fragmented systems of care.
Amid inflationary pressures, changing consumer behavior, and rising sustainability awareness, Supply Chain Management (SCM) has evolved from a logistical function into a core driver of business strategy. Companies no longer see SCM merely as a cost-control tool. Instead, they are adopting automation and smart technologies to improve visibility and process efficiency, turning it into a key driver of pricing strategy, customer experience, and service flexibility (KPMG, 2025). Today, SCM plays a critical role in driving business growth and organizational resilience.
In Thailand, Solventum partners with DKSH to ensure the safe, efficient, and reliable distribution of its comprehensive dental portfolio. Together, they are expanding access to high-integrity dental care, supporting clinicians’ confidence, and improving patient outcomes nationwide.
Once viewed as a stakeholder bonus or compliance exercise, green logistics is now a defining measure of business resilience, cost-efficiency, and corporate responsibility. As logistics accounts for 11% of global greenhouse gas emissions – according to the World Economic Forum (WEF) – and freight volumes continue to climb, the sector faces mounting pressure to decarbonize. The pressure goes beyond regulation, reflecting a growing business case for long-term competitiveness, part of which includes sustainable practices to reduce emissions, lower costs, and offer insurance against geopolitical and economic shocks.
DKSH is transforming healthcare logistics in Northern Thailand through the rollout of its first satellite distribution center, with plans to expand the model nationwide. By placing supply hubs closer to where care happens, DKSH empowers frontline medical teams to respond quickly, maintain smooth operations, and ultimately, deliver timely and effective patient care.
As technological innovation continues to reshape industries, Artificial Intelligence (AI) is emerging as a powerful force in the transformation of healthcare. The sector is undergoing a fundamental shift with AI offering a transformative means of improving patient outcomes, operational efficiency, and cost-effectiveness. In Southeast Asia, the integration of AI technologies is helping health systems cope with mounting pressures, such as an aging population, rising healthcare costs, and the need for faster, more accurate care delivery.
Southeast Asia’s pharmaceutical industry is undergoing a significant transformation. With a population exceeding 660 million and a rising burden of chronic and infectious diseases, the region’s demand for innovative medicines and medical devices is surging.
Patient Purpose Day brought our mission of “Healthcare for All” to life through locally driven, patient-centric initiatives across 11 markets. By empowering teams and engaging communities, we reinforced our purpose, strengthened our brand, and advanced better care for those who need it most.
Contact us to discover new opportunities.